Our Medications

Please refer to each medication’s prescribing information and medication guide or patient information for specific details.

To report an adverse event, please call 1‑800‑445‑3235 (option #3) 24 hours/day, 7 days/week.

Explore active and recruiting clinical trials
Results (26)

Atripla®

efavirenz 600 mg/emtricitabine 200 mg/tenofovlr disoproxil fumarate 300 mg

Biktarvy®

bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg

Complera®

emtricitabine 200 mg/rilpivirine 25 mg/tenofovir disoproxil fumarate 300 mg

Genvoya®

elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200mg/tenofovir alafenamide 10 mg

Odefsey®

emtricitabine 200 mg/rilpivirine 25 mg/tenofovir alafenamide 25 mg

Stribild®

elvitegravlr 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg

Sunlenca®

lenacapavir injection 463.5 mg/1.5 mL; lenacapavir tablets 300 mg

Vosevi®

sofosbuvir 400 mg/velpatasvir 100 mg/voxilaprevir 100 mg tablets